SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hepta AI Reports MRE-Level Accuracy in Identifying Patients for MASH Drugs

Hepta says its AI can read liver biology from a routine blood draw and identify patients for newly approved MASH drugs with accuracy comparable to MRE. The body is truncated.

Related stories